
510(k) clearance given to product for use in real-time surgery.

Eight recommendations released for imaging women post-mastectomy and breast reconstruction.

In a time when interoperability could be key, facilities have fewer resources to make it a priority.

Dr. Eliot Siegel discusses benefits, cautions, and long-term impact of using AI imaging tools during the outbreak.

Dr. Eliot Siegel discusses the role these tools play, as well as the challenges radiologists could encounter with using them.

Recommendations look to bring needed imaging equipment to facilities faster.

Younger patients have milder symptoms, fewer positive CT scans, and less lung involvement.

Real world guidance to protect both you and your patients.

Using AI technologies when imaging isn’t recommended for detection offers little benefit, according to an industry expert.

Eight-ounce scanner assesses heart function.

Shortened protocol identifies more cancers than ultrasound or mammography.

Combining both modalities is an acceptable alternative to MRI, study finds.

Behold.ai receives approval for red dot® imaging recognition algorithm.

Low-dose procedures and shifting in imaging are credited for the decline.

Software derives biomarkers designed to monitor respiratory disease.

Researchers identified significant DNA breaks and chromosome aberrations with standard-dose CT; no impact from low-dose scans.

Digital breast tomosynthesis identifies more aggressive cancers with fewer false positives than traditional mammography over the long term.

ScreenPoint Medical receives greenlight for Transpara™ 1.6.0. to reduce read times.

Contacting patients via cell phone can save time, money, and resources.

In this new series, we explore the life radiologists lead outside the reading room.

Priority Work List could enhance analysis and reduce false negatives.

Early career might not be the best time for a teleradiology position.

Continued screening in older age doesn’t provide greater survival benefit.

Superior diagnosis with CT requires safety planning.

Emagine Solutions Technology cleared to market VistaScan platform.

Vendor-agnostic service, called Skeye, offers risk protection through AI tools and remote threat management.

Various findings on CT can indicate how far a patient has progressed along disease timeline.

Screening mammography can improve triple-negative breast cancer survival rates for African-American women.

KinetiCor, Inc., secured FDA clearance for system used on Siemens Healthineers MRI Scanner.